TCRX vs TOST · rev $2.0M vs P/E 161, rev $3.54B
Tscan Therapeutics Inc (TCRX) versus Toast Inc (TOST) — a side-by-side from cached financials, not a winner call.
Tscan Therapeutics Inc (TCRX) is a biotechnology company listed on NASDAQ.
Toast Inc (TOST) is a software - infrastructure company listed on US.
Latest reported TCRX revenue for 2026-06-30 was $2.0M. Net income was -$59.0M. TCRX currently screens at market cap $62.1M.
Latest reported TOST revenue for 2026-06-30 was $3.54B. Net income was $280.0M. TOST currently screens at market cap $25.21B and trailing P/E 161.4.
TCRX currently screens at market cap $62.1M. TOST currently screens at market cap $25.21B and trailing P/E 161.4.
Not investment advice. Open the TCRX and TOST stock pages for the full models.
Not investment advice.